• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Hybrid No Mo’









Hybrid Working ends 11/1/24.

I hear it’s because they want the folks at Taro to quit rather than pay out severance.

Nice strategy Cow Face.
That’s not at all surprising.

This is a culture that belittles its employees around the world. Think about this: some Sun facilities have buckets and ladles.
Yeah. Really.